Abstract
Success in achieving remissions of acute myelogenous leukemia (AML) since the 1950s, and especially since the mid-1970s, has developed a need for greater attention on the part of physicians to improved methods for diagnosing and classifying the leukemias. The majority of AML patients can achieve first remissions, some (5–10%) lasting several years; these prolonged survivors are presumably cured of their leukemia. Many AML patients, however, are still not receiving the benefits of improved diagnostic methods and intensive therapeutic regimens. Of the latter group 80% are dead within a year of diagnosis [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Powles R, McElwain T. Introduction: Leukemia and lymphoma. Semin Hematol 19 (3) 153–154, 1982.
Lister TA, Rohatiner A7.S. The treatment of acute myelogenous leukemia in adults. Semin Hematol 19 (3): 172–192, 1982.
Hanker JS. Ambrose WW, James CJ. Mandelkorn J, Yates PE, Gall SA, Bossen EH, Fay JW, Laszlo J, Moore JO. Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res. 39: 1635–1639. 1979.
de Salvo Cardullo L, Morilla R, Catovsky D. Significance ot phi bodies in acute leukemia. J Clin Pathol 34: 153–157, 1981.
Catovsky D, de Salvo Cardullo L, O’Brien M, Morilla R. Costello C, Galton D, Ganeshaguru K, Hoffbrand V. Cytochemical markers of differentiation in acute leukemia. Cancer Res. 41 (11): 4824–4832, 1981.
Catovsky D. Crockard AD, Matutes E, O’Brien M. Cytochemistry of leukemic cells. In: Stoward PJ. Polak JM, eds. Histochemistry: The widening horizons of its applications in the biomedical sciences. Chichester, England: John Wiley & Sons, 1981, pp. 67–88.
Jansson S-E, Gripenberg J, Vuopio P, Teerenhovi I., Andersson LC. Classification of acutc leukaemia by light and electron microscope cytochemistrv. Scand J Haematol 25: 412–416, 1980.
Tricot G, Broeckaert-van Orshoven A, Van Hoof A, Verwilghen RL. Sudan black B positivity in acute lymphoblastic leukaemia. Br J Haematol 51 (4): 615–621, 1982.
Hanker JS, Romanovicz DK. Phi bodies: Peroxidase particles that produce crystal-loidal cellular inclusions. Science 197: 895–898, 1977.
Youness E, Trujillo JM, Ahearn MJ, McCredie KB, Cork A. Acute unclassified leukemia: A clinicoparhologic study with 44 diagnostic implications of electron microscopy. Am J Hematol 9: 79–88, 1980.
Reiffers J, Broustct A. Acutc myeloblasts leukemia masquerading as null-cell acute lymphoblastic leukemia. New Engl J Med 304: 1238–1239, 1981.
McCarty, Jr KS, Wortman J, Daly J, Rundies RW, Hanker JS. Chloroma (granulocytic sarcoma) without evidence of leukemia: Facilitated light microscopic diagnosis. Blood 56 (1): 104–108, 1980.
Hanker JS. Yates PE, Met?. CB, Rustioni A. A new specific, sensitive and noncar- cinogenic reagent for the demonstration of horseradish peroxidase. Histochcm J 9:789–792, I9?7.
Hanker JS, Giammara BL. Hemo-proteinopathy: molecular aggregation accompanying malignancy. Med Hypoth 7: 77–83, 1981.
Hanker JS, Giammara BL. Hematology: Some advances and insights from histocytochemical and molecular biological studies of haemoproteins. In: Stoward PJ, Polak JM, eds. Histochemistry: The widening horizons of its applications in the biomedical sciences. Chichester, England: John Wiley & Sons. pp. 89–108. 1981.
Hanker JS, Laszlo J, Moore JO. The light microscopic demonstration of hydroperoxidasc-positive phi bodies and rods in leukocytes in acute myeloid leukemia. Histochemistry 58: 241–252, 1978.
Carovsky D. Symposium: classification of leukemia: I. The classification of acute leukaemia. Pathology 14: 277–281, 1982.
Bainton DF, Farquhar MG. Differences in enzyme Content of azurophil and specific granules of polymorphonuclear leukocytes: I. Histochemical staining of bone marrow smears. J Ceil Biol 39: 286–298. 1968.
Graham RC Jr, Karnovsky MJ. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14: 291–302. 1966.
Hanker JS, Ellis, LC, Jr, Rustioni A. Carson KA. Reiner A. Eldred W, Karten HJ. The ultrastructural demonstration of the retrograde axonal transport of horseradish peroxidase in nervous tissues by transmis¬sion and high voltage electron microscopy. In: Johnson JE, Jr ed. Current trends inc morphological research, vol. 1 Boca Raton. La.: CRC Press, 1981, pp. 55–91.
Tubbs RR, Sheibani K, Deodhar SD, Hawk WA. Enzyme immunohistochemistry: Review of technical aspects and diagnostic applications. Cleveland Clin Q 48 (2): 245–28l, 1981.
Sheibani K. Tubbs RR. Gephardt GN,.McMahon JT, Valenzuela R. Comparison of alternative chromogens for renal immunohistochemistry. Human Pathol 12: 349–354, 1981.
Tubbs RR, Sheibani K. Chromogens for immunohistochemistry. Arch Pathol Lab Med 106 (4): 205, 1982.
Cabrillat H, Fontamiere B. Paraphenvl- enediamine-pyrocatechol: An alternative substrate to diaminobenzidine for the demonstration of endogenous peroxidase of mammalian leucocytes. Histochem J 12: 488–491, 1980.
Sheibani K, Lucas FV. Tubbs RO. Savage RA, Hoeltge GA. Alternate chromogens as substitutes for benzidine for myeloperoxidase cytochemistry. Am J Clin Pathol 75: 367–370, 1981.
Lison L. Sur de nouveaux colorants histologiques spécifiques des lipides. C R Soc Biol 115: 202–205, 1934.
Lison L. Sur la recherche histochemique des oxydases par le reaction du bleu d’in-dophenol. Bull Soc Chim Biol 18: 185–189, 1936.
Ullie RD, Burtner HJ. Stable sudanophilia of human neutrophil leucocytes in relation to peroxidase and oxidase. J Histochem Cytochem 1: 8–25, 1953.
Sheehan HL, Storey GW. An improved method of staining leukocyte granules with Sudan black B. J Pathol Bact 59 336. 1947.
Mandelkorn J, Silverman MS, Harrison JE. Hanker JS. Immunofluorescent demonstration of myeloperoxidase of phi bodies and rods in leukaemic leucocytes. Histochem J 12: 449–456. 1980.
Hanker JS. Chandross RJ. Solic JJ. Weath- erly NF, Laszlo J, Moore JO, Ottolenghi A. Medusa cells: Cytostructure and cyto¬chemistry of amoeboid eosinophils with pseudopod-like processes. Histochem J 13: 905–919. 1981.
Hanker JS. Chandross RJ. Weatherly NF. Laszlo J. Moore JO. Buckley RH, Ottolenghi A. Medusa cells: The morphology and 3. cytochemistry of common amoeboid variations of eosinophils. Histochem J 12: 701–707, 1980.
Hanker JS, Silverman MS, Romanovicz DK. Catalase in salivary gland striated and excretory duct cells: II. Ф body, an ellipsoidal peroxisomal organelle with crystalloid axial projections. Histochem J. 9: 7 29–744. 1977.
Yamada M, Mori M, Sugimura T. Purification and characterization of small molecular weight myeloperoxidase from human promyelocyte leukemia HL-60 cells. Biochemistry 20: 766–771, 1981.
Stass SA. Holloway ML, Peterson V, Creegan WJ. Gallivan M, Schumacher 11R. Cytoplasmic fragments causing spurious platelet counts in the leukemic phase of poorly differentiated lymphocytic Ivmphoma. Am J Clin Pathol 71125–128, 1979-
Stass SA. Holloway ML, Slease RB. Schumacher HR. Spurious platelet counts in hairy cell leukemia. Am J Clin Pathol 68: 350–351, 1977.
Conjalka M, Rajdev N, Tavassoli M. Lymphoreticular fragments: The Cellular debris of acute lymphosarcoma cell leukemia. Cancer 44: 2124–2126. 1979.
Armitage JO. Goeken JA, Feagler JR Spurious elevation of the platelet count in acute leukemia, J Am Med Assn 239: 433–434. 1978.
Hanker JS, Giammara BL. Neutrophil pseudoplatelets: Their discrimination by myeloperoxidase demonstration. Science 220: 415–417, 1983.
Hanker JS. Ambrose WW. Yates PE.. Moore JO. Arnn ET, Giammara BL. Neutrophil pseudoplatelets: Elucidation and identification by myeloperoxidase demonstration. Submitted to Histochem J.
Breton-Gorius J, Reyes F, Duhamel G. Najman A, Gorin AC. Megakaryoblascic acute leukemia: Identification by the ultra- structural demonstration of platelet peroxidase. Blood 51: 45–60. 1978.
Edelson PJ. Cohn ZA. Peroxidasc- mediated mammalian cell cytotoxicity. J Exp Med 138:318–323, 197 3.
Clark RA, Klebanoff SJ. Neutrophil- mediated tumor cell toxicity: Role of the peroxidase system. J Exp Med 141: 1442–1447, 1975.
Clark RA. Szot R The myeloperoxidase- hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity..J Immunol 126: 1295–1301. 1981.
Clark RA, Olsson I, Klebanoff SJ Cytotoxicity for tumor cells of canonic proteins from human neutrophil granules. J Cell Biol 70: 719–723, 1976.
Nathan C. Cohn Z. Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages. J Exp Med 152: 198–208. 1980.
Maldonado JF. The ultrastructure of the platelets in refractory anemia (“preleukemia”) and myelomonocytic leukemia. Ser Hematol 8: 101–125. 1975.
Maldonado JE. Platelet granulopathy. A new morphologic feature in preleukemia and myelomonocytic leukemia: Light microscopy and ultrastruaural morphology and cytochemistry. Mayo Clin Proc 51: 452–462. 1976.
Lichtman MA. Cellular deformability dur¬ing maturation of the myeloblast: Possible- role in marrow egress. New Engl J Med 283: 943–948. 1970.
Merz, B. Newly identified particle may explain spuriously elevated platelet count. J Am Med Assn 239: 3146–5147, 1983.
Gill GW. Frost JK, Miller KA. A new formula for a half-oxidized hematoxylin solution that neither overstains nor requires differentiation. Acta Cytol 18: 300–311. 1974.
Yam LT. Li CY. Crosby WH. Cytochem- ical identification of monocytes and granulocytes. Am J Clin Path 55: 28 3–290. 1971.
Berman EL, Carter HW. Ambrose WW. Hanker JS. Studies of eosinophil medusa cells by electron imaging modes. Scanning Electron Microscopy pp. 311–321, 1983.
Sigma Technical Bulletin no. 390. Sigma Chemical Co., P.O. Box 14508. St. Louis. MO 63178.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston/The Hague/Dordrecht/Lancaster
About this chapter
Cite this chapter
Hanker, J.S. et al. (1984). Significance of Improved Cytochemical Methods for Hemoprotein Enzymes in Diagnosis and Classification of Leukemia. In: Polliack, A. (eds) Human Leukemias. Developments in Oncology Series, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2823-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2823-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9785-7
Online ISBN: 978-1-4613-2823-0
eBook Packages: Springer Book Archive